Invention Grant
US08110182B2 Treatment of multiple sclerosis by administration of interferon alpha and C-phycocyanin
失效
通过施用干扰素α和C-藻蓝蛋白治疗多发性硬化症
- Patent Title: Treatment of multiple sclerosis by administration of interferon alpha and C-phycocyanin
- Patent Title (中): 通过施用干扰素α和C-藻蓝蛋白治疗多发性硬化症
-
Application No.: US12091776Application Date: 2006-10-30
-
Publication No.: US08110182B2Publication Date: 2012-02-07
- Inventor: Giselle Penton Rol , Majel Cervantes Llanos , Eduardo Penton Arias , Diana Garcia del Barco Herrera , Carmen Maria Valenzuela Silva , Pedro Antonio Lopez Saura , Gerardo Enrique Guillen Nieto
- Applicant: Giselle Penton Rol , Majel Cervantes Llanos , Eduardo Penton Arias , Diana Garcia del Barco Herrera , Carmen Maria Valenzuela Silva , Pedro Antonio Lopez Saura , Gerardo Enrique Guillen Nieto
- Applicant Address: CU Cuidad de La Habana
- Assignee: Centro de Ingenieria Genectica y Biotecnologia
- Current Assignee: Centro de Ingenieria Genectica y Biotecnologia
- Current Assignee Address: CU Cuidad de La Habana
- Agency: Hoffmann & Baron, LLP
- Priority: CU2005-0207 20051028
- International Application: PCT/CU2006/000012 WO 20061030
- International Announcement: WO2007/048357 WO 20070503
- Main IPC: A61K38/20
- IPC: A61K38/20 ; A61K31/33 ; C07K14/56 ; C07K14/41
Abstract:
The present invention consists of the combination of Interferon alpha and C-Phycocyanin (IFN-α/C-Phyco) for obtaining a pharmaceutical preparation for autoimmune disease, allergy and cancer treatments. The anti-inflammatory, immunomodulator, antioxidant, anti-viral, anti-proliferative and anti-tumoral effects, associated to the regulatory T cell inducer effect demonstrated in this invention is the rationale for the use of the IFN-α/C-Phyco combination in these diseases.
Public/Granted literature
- US20090280087A1 Interferon AlPha And C-Phycocyanin For The Treatment Of Autoimmune Diseases, Allergy And Cancer Public/Granted day:2009-11-12
Information query
IPC分类:
